| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6190427 | Cancer Treatment Reviews | 2016 | 6 Pages |
Abstract
Patients with advanced breast cancer with visceral involvement and longer time from diagnosis to recurrence had significantly better TTP/PFS with the use of fulvestrant. These results may have implications for selection of patients in the design of future clinical trials and to inform treatment decisions in clinical practice.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jeffrey Graham, Marshall Pitz, Vallerie Gordon, Debjani Grenier, Eitan Amir, Saroj Niraula,